494 related articles for article (PubMed ID: 9298521)
1. Time-course of deactivation of rat stomach ECL cells following cholecystokinin B/gastrin receptor blockade.
Ding XQ; Lindström E; Håkanson R
Br J Pharmacol; 1997 Sep; 122(1):1-6. PubMed ID: 9298521
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin-B/gastrin receptor blockade suppresses the activity of rat stomach ECL cells.
Ding XQ; Lindström E; Håkanson R
Pharmacol Toxicol; 1997 Jul; 81(1):19-25. PubMed ID: 9258980
[TBL] [Abstract][Full Text] [Related]
3. CCK2 receptor antagonists: pharmacological tools to study the gastrin-ECL cell-parietal cell axis.
Håkanson R; Ding XQ; Norlén P; Lindström E
Regul Pept; 1999 Mar; 80(1-2):1-12. PubMed ID: 10235629
[TBL] [Abstract][Full Text] [Related]
4. Effect of cholecystokinin-2 receptor blockade on rat stomach ECL cells. A histochemical, electron-microscopic and chemical study.
Chen D; Zhao CM; Norlén P; Björkqvist M; Ding XQ; Kitano M; Håkanson R
Cell Tissue Res; 2000 Jan; 299(1):81-95. PubMed ID: 10654072
[TBL] [Abstract][Full Text] [Related]
5. Reversibility of cholecystokinin-B/gastrin receptor blockade: a study of the gastrin-ECL cell axis in the rat.
Norlén P; Lindström E; Ding XQ; Kitano M; Håkanson R
Pharmacol Toxicol; 1999 Apr; 84(4):159-64. PubMed ID: 10227066
[TBL] [Abstract][Full Text] [Related]
6. Functional impairment of the individual rat stomach ECL cell in response to sustained hypergastrinemia.
Kimura K; Chen D; Lindström E; Yamada H; Zhao CM; Håkanson R
Regul Pept; 1997 Oct; 72(2-3):69-77. PubMed ID: 9652979
[TBL] [Abstract][Full Text] [Related]
7. Depletion of enterochromaffin-like cell histamine increases histidine decarboxylase and chromogranin A mRNA levels in rat stomach by a gastrin-independent mechanism.
Andersson K; Lindström E; Chen D; Monstein HJ; Boketoft A; Håkanson R
Scand J Gastroenterol; 1996 Oct; 31(10):959-65. PubMed ID: 8898415
[TBL] [Abstract][Full Text] [Related]
8. Acute responses of rat stomach enterochromaffinlike cells to gastrin: secretory activation and adaptation.
Chen D; Monstein HJ; Nylander AG; Zhao CM; Sundler F; Håkanson R
Gastroenterology; 1994 Jul; 107(1):18-27. PubMed ID: 7517373
[TBL] [Abstract][Full Text] [Related]
9. Role of gastrin in the development of gastric mucosa, ECL cells and A-like cells in newborn and young rats.
Björkqvist M; Dornonville de la Cour C; Zhao CM; Gagnemo-Persson R; Håkanson R; Norlén P
Regul Pept; 2002 Oct; 108(2-3):73-82. PubMed ID: 12220729
[TBL] [Abstract][Full Text] [Related]
10. Expression of the chromogranin A-derived peptides pancreastatin and WE14 in rat stomach ECL cells.
Norlén P; Curry WJ; Chen D; Zhao CM; Johnston CF; Håkanson R
Regul Pept; 1997 Jun; 70(2-3):121-33. PubMed ID: 9272624
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological analysis of CCK2 receptor antagonists using isolated rat stomach ECL cells.
Lindström E; Björkqvist M; Håkanson R
Br J Pharmacol; 1999 May; 127(2):530-6. PubMed ID: 10385255
[TBL] [Abstract][Full Text] [Related]
12. Long-lasting cholecystokinin(2) receptor blockade after a single subcutaneous injection of YF476 or YM022.
Kitano M; Norlén P; Ding XQ; Nakamura S; Håkanson R
Br J Pharmacol; 2000 Jun; 130(3):699-705. PubMed ID: 10821801
[TBL] [Abstract][Full Text] [Related]
13. Gastric submucosal microdialysis: a method to study gastrin- and food-evoked mobilization of ECL-cell histamine in conscious rats.
Kitano M; Norlén P; Håkanson R
Regul Pept; 2000 Jan; 86(1-3):113-23. PubMed ID: 10672910
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of three novel cholecystokinin-B/gastrin receptor antagonists: a study of their effects on rat stomach enterochromaffin-like cell activity.
Ding XQ; Lindström E; Håkanson R
Pharmacol Toxicol; 1997 Nov; 81(5):232-7. PubMed ID: 9396089
[TBL] [Abstract][Full Text] [Related]
15. Altered influence of CCK-B/gastrin receptors on HDC expression in ECL cells after neoplastic transformation.
Kölby L; Wängberg B; Ahlman H; Modlin IM; Theodorsson E; Nilsson O
Regul Pept; 1999 Dec; 85(2-3):115-23. PubMed ID: 10651065
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the specificity and potency of a series of cholecystokinin-B/gastrin receptor antagonists in vivo.
Ding XQ; Håkanson R
Pharmacol Toxicol; 1996 Sep; 79(3):124-30. PubMed ID: 8884870
[TBL] [Abstract][Full Text] [Related]
17. ECL cells: biology and pathobiology.
Håkanson R; Chen D; Tielemans Y; Andersson K; Ryberg B; Sundler F; Mattsson H
Digestion; 1994; 55 Suppl 3():38-45. PubMed ID: 7698536
[TBL] [Abstract][Full Text] [Related]
18. Effect of cholecystokinin-B/gastrin receptor blockade on gastric acid secretion in conscious rats.
Ding XQ; Håkanson R
Pharmacol Toxicol; 1996 Dec; 79(6):324-30. PubMed ID: 9000260
[TBL] [Abstract][Full Text] [Related]
19. Sustained cholecystokinin-B/gastrin receptor blockade does not impair basal or histamine-stimulated acid secretion in chronic gastric fistula rats.
Ding XQ; Kitano M; Håkanson R
Pharmacol Toxicol; 1998 Apr; 82(4):177-82. PubMed ID: 9584331
[TBL] [Abstract][Full Text] [Related]
20. Rat stomach ECL-cell histidine decarboxylase activity is suppressed by ergocalciferol but unaffected by parathyroid hormone and calcitonin.
Gagnemo-Persson R; Persson P; Bryngelsson T; Greén B; Håkanson R
Regul Pept; 1999 Feb; 79(2-3):131-9. PubMed ID: 10100926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
